$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
尼拉帕利国内怎么买?
2025-10-19 11:44:20
Check Details
尼拉帕利推荐的用量多少呢?
2025-10-19 11:44:20
Check Details
尼拉帕利要怎么服用?
2025-10-19 11:44:20
Check Details
尼拉帕利的用法和用量
2025-10-19 11:44:20
Check Details
尼拉帕利 说明书
2025-10-19 11:44:20
Check Details
尼拉帕利适用于治疗什么病症?
2025-10-19 11:44:20
Check Details
用尼拉帕利可能出现耐药的情况吗?
2025-10-19 11:44:20
Check Details
怎么服用尼拉帕利呢?
2025-10-19 11:44:20
Check Details
尼拉帕利去哪买呢?
2025-10-19 11:44:20
Check Details
尼拉帕利在中国上市了吗?
2025-10-19 11:44:20
Check Details
尼拉帕利纳入医保没?
2025-10-19 11:44:20
Check Details
尼拉帕利是哪生产的呢?
2025-10-19 11:44:20
Check Details
1
2
...
1754
1755
1756
1757
1758
1759
1760
...
4159
4160
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
2
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
3
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
4
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
5
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
6
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
7
Lapatinib: Proper Administration Guide and Key Precautions
8
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
9
Cemiplimab Storage and Handling Guide
10
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
11
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring
12
Encorafenib (Braftovi): Comprehensive Guide to BRAF V600 Inhibitor Indications, Dose Regimens by Tumor Type, and Administration Requirements